NR4A1 and breast carcinoma: Considering the different treatment options of breast cancer in accordance with their hormone receptor status and molecular subtype with varying associations with risk factors for incidence, response to treatment and risk of disease progression, our results demonstrate the potential for non-invasive whole-tumor tissue classification.